Mesothelioma Treatment Approved by FDA, First in 15 Years

Doctor examining x-ray of mesothelioma patient

For the first time in 15 years, the United States Food and Drug Administration (FDA) has approved a new treatment for mesothelioma, a rare and aggressive form of cancer that has been proven to be caused by exposure to asbestos. The NovoTTF-100L System was made by Novocure and uses electric fields to stop mesothelioma tumors from dividing.

The treatment device was approved under the Humanitarian Device Exemption, which was created to encourage innovation in rare diseases. Another Novocure device, Optune, was approved by the FDA in 2011, for the treatment of glioblastoma, a form of brain cancer.


What is Mesothelioma?

Mesothelioma is a deadly cancer which strikes the protective lining of the body’s organs – most commonly the lungs or abdomen – and is almost always linked to exposure to asbestos, a naturally occurring fiber that had been used in a wide range of industries, such as construction and automobile parts manufacturing. Mesothelioma can take up to decades to develop, but when a diagnosis is made, the prognosis is grim.

Mesothelioma is a preventable disease that almost always results from the negligent and dangerous actions of employers, building owners or contractors, or manufacturers. In these cases, the law provides an opportunity for recovery, enabling compensation and justice for those who were harmed and the family of those who suffered a wrongful death. The mesothelioma law firm of Cooney & Conway has obtained answers and accountability for mesothelioma victims and their families for decades.

For additional information, assistance and support, call Cooney & Conway toll-free at 800-322-5573, or simply fill out the contact form to the right and a knowledgeable representative will respond shortly.